Stock market week-in-review for 5 large GI companies — Aug. 28-Sept. 1

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 28 to Sept. 1, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $222.13 on Aug. 28
Peaked: $231.22 on Sept. 1
Closed: $227.70 on Sept. 1
Percent change between Aug 28 to Sept. 1: 2.5 percent

2. Exact Sciences Corp.

Opened: $40.49 on Aug. 28
Peaked: $41.99 on Aug. 31
Closed: $41.61 on Sept. 1
Percent change between Aug 28 to Sept. 1: 2.76 percent

3. Johnson & Johnson

Opened: $131.73 on Aug. 28
Peaked: $132.58 on Sept. 1
Closed: $131.01 on Sept. 1
Percent change between Aug 28 to Sept. 1: -0.54 percent

4. Synergy Pharmaceuticals

Opened: $3.12 on Aug. 28
Peaked at open
Closed: $3.01 on Sept. 1
Percent change between Aug 28 to Sept. 1: -3.52 percent

5. Valeant Pharmaceuticals

Opened: $14.03 on Aug. 28
Peaked: $14.26 on Aug. 28
Closed: $13.32 on Sept. 1
Percent change between Aug 28 to Sept. 1: -5.06 percent

More articles on gastroenterology:
What 15 healthcare practices pay their gastroenterologists — $458k is #1
Gastroenterologists, payers possibly thwarting biosimilar adaptation — 4 key notes
‘Relentless dedication to IBD care’ — How 3 GI leaders will use their Sherman Prizes to enhance IBD, Crohn’s treatment

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.